These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2816645)

  • 41. Benign intrinsic tectal "tumors" in children.
    May PL; Blaser SI; Hoffman HJ; Humphreys RP; Harwood-Nash DC
    J Neurosurg; 1991 Jun; 74(6):867-71. PubMed ID: 2033445
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MRI of intracranial germ cell tumours.
    Sumida M; Uozumi T; Kiya K; Mukada K; Arita K; Kurisu K; Sugiyama K; Onda J; Satoh H; Ikawa F
    Neuroradiology; 1995 Jan; 37(1):32-7. PubMed ID: 7708186
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of MR spectroscopy and MR imaging with contrast agent in children with cerebral astrocytomas.
    Dezortová M; Hájek M; Cáp F; Babis M; Tichý M; Vymazal J
    Childs Nerv Syst; 1999 Aug; 15(8):408-12. PubMed ID: 10447614
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnetic resonance imaging of experimental rat brain tumors: histopathological evaluation.
    Baba T; Moriguchi M; Natori Y; Katsuki C; Inoue T; Fukui M
    Surg Neurol; 1990 Dec; 34(6):378-82. PubMed ID: 2244301
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sturge-Weber syndrome: cranial MR imaging with Gd-DTPA.
    Benedikt RA; Brown DC; Walker R; Ghaed VN; Mitchell M; Geyer CA
    AJNR Am J Neuroradiol; 1993; 14(2):409-15. PubMed ID: 8456721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gadolinium-DTPA-enhanced MRI of intraocular tumors.
    Adam G; Brab M; Bohndorf K; Günther RW
    Magn Reson Imaging; 1990; 8(6):683-9. PubMed ID: 2266793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pre- and postcontrast MR studies in tuberous sclerosis.
    Wippold FJ; Baber WW; Gado M; Tobben PJ; Bartnicke BJ
    J Comput Assist Tomogr; 1992; 16(1):69-72. PubMed ID: 1729309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gd-DTPA-enhanced MR detection of diffuse leptomeningeal metastases.
    Cooley PA; Czarnecki DJ; Sty JR
    AJR Am J Roentgenol; 1989 Oct; 153(4):888. PubMed ID: 2549770
    [No Abstract]   [Full Text] [Related]  

  • 49. Neuroblastoma: evaluation with contrast enhanced MR imaging.
    Kornreich L; Horev G; Kaplinsky C; Ziv N; Grünebaum M
    Pediatr Radiol; 1991; 21(8):566-9. PubMed ID: 1815177
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MR susceptibility weighted imaging (SWI) complements conventional contrast enhanced T1 weighted MRI in characterizing brain abnormalities of Sturge-Weber Syndrome.
    Hu J; Yu Y; Juhasz C; Kou Z; Xuan Y; Latif Z; Kudo K; Chugani HT; Haacke EM
    J Magn Reson Imaging; 2008 Aug; 28(2):300-7. PubMed ID: 18666142
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MRI findings in children with neurofibromatosis type 1: a prospective study.
    Van Es S; North KN; McHugh K; De Silva M
    Pediatr Radiol; 1996 Jul; 26(7):478-87. PubMed ID: 8662066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiologic classification of brain stem tumors: correlation of magnetic resonance imaging appearance with clinical outcome.
    Fischbein NJ; Prados MD; Wara W; Russo C; Edwards MS; Barkovich AJ
    Pediatr Neurosurg; 1996; 24(1):9-23. PubMed ID: 8817611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety and efficacy of gadoteric acid in pediatric magnetic resonance imaging: overview of clinical trials and post-marketing studies.
    Balassy C; Roberts D; Miller SF
    Pediatr Radiol; 2015 Nov; 45(12):1831-41. PubMed ID: 26045036
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contrast-enhanced MR imaging of malignant brain tumors.
    Graif M; Bydder GM; Steiner RE; Niendorf P; Thomas DG; Young IR
    AJNR Am J Neuroradiol; 1985; 6(6):855-62. PubMed ID: 3934926
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can nonenhancing white matter lesions in cancer patients be disregarded?
    Elster AD; Chen MY
    AJNR Am J Neuroradiol; 1992; 13(5):1309-15; discussion 1316-8. PubMed ID: 1414820
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Whole-body magnetic resonance imaging: a useful additional sequence in paediatric imaging.
    Laffan EE; O'Connor R; Ryan SP; Donoghue VB
    Pediatr Radiol; 2004 Jun; 34(6):472-80. PubMed ID: 15107961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do we need gadolinium-based contrast medium for brain magnetic resonance imaging in children?
    Dünger D; Krause M; Gräfe D; Merkenschlager A; Roth C; Sorge I
    Pediatr Radiol; 2018 Jun; 48(6):858-864. PubMed ID: 29623352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Pharmacokinetics, Efficacy, and Safety Study of Gadoterate Meglumine in Pediatric Subjects Aged Younger Than 2 Years.
    Scala M; Koob M; de Buttet S; Bourrinet P; Felices M; Jurkiewicz E
    Invest Radiol; 2018 Feb; 53(2):70-79. PubMed ID: 28906338
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.
    Colosimo C; Demaerel P; Tortori-Donati P; Christophe C; Van Buchem M; Högström B; Pirovano G; Shen N; Kirchin MA; Spinazzi A
    Pediatr Radiol; 2005 May; 35(5):501-10. PubMed ID: 15678342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MR contrast media in neuroimaging: a critical review of the literature.
    Breslau J; Jarvik JG; Haynor DR; Longstreth WT; Kent DL; Maravilla KR
    AJNR Am J Neuroradiol; 1999 Apr; 20(4):670-5. PubMed ID: 10319979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.